Analytical Data
-
基因名
FCRL6
- Application
-
别名
FCRL6；FCRH6；Fc receptor-like Protein 6
-
种属
Human
-
表达系统
E. coli
-
标签
His tag N-Terminus
-
纯度
Greater than 90% as determined by SDS-PAGE.
-
蛋白编号
Q6DN72
-
表达区间
20-307aa
-
氨基酸序列
LYLQAWPNPVFEGDALTLRCQGWKNTPLSQVKFYRDGKFLHFSKENQTLS MGAATVQSRGQYSCSGQVMYIPQTFTQTSETAMVQVQELFPPPVLSAIPS PEPREGSLVTLRCQTKLHPLRSALRLLFSFHKDGHTLQDRGPHPELCIPG AKEGDSGLYWCEVAPEGGQVQKQSPQLEVRVQAPVSRPVLTLHHGPADPA VGDMVQLLCEAQRGSPPILYSFYLDEKIVGNHSAPCGGTTSLLFPVKSEQ DAGNYSCEAENSVSRERSEPKKLSLKGSQVLFTPASNW
-
分子量
47 kDa
-
内毒素
< 1.0 EU per μg protein as determined by the LAL method.
-
性状
Freeze-dried powder
-
缓冲液
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
复溶方法
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- 个性化定制
-
稳定性测试
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
保存条件 & 期限
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
运输条件
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
FCRL6, or Fc receptor-like 6, is a member of the Fc receptor-like family, which plays a significant role in the immune system by regulating various immune responses. This receptor is predominantly expressed on B cells and certain immune cells, indicating its crucial function in immune regulation and signaling. Recent studies have highlighted FCRL6's involvement in autoimmune diseases, infections, and tumor immunity, suggesting it may serve as a potential biomarker or therapeutic target. Recombinant FCRL6 protein research has gained interest due to its ability to interact with immunoglobulins and influence B cell differentiation, activation, and survival. Understanding the structure and function of FCRL6 through recombinant protein studies could provide insights into its role in modulating immune responses and its potential implications for treating immune-related disorders. Consequently, the generation of FCRL6 recombinant proteins is vital for investigating its biochemical properties and therapeutic potential, facilitating the development of novel strategies to manipulate immune responses in various clinical contexts.
